-
Medicure Focuses OnDevelopment & Commercialization
of Cardiovascular Therapeutics
For the U.S Market -
medicure is traded
on TSX Venture (MPH)The Company’s primary operating focus is on the sale and marketing of its acute care cardiovascular drug, AGGRASTAT (tirofiban HCI).
